Skip to main content

Table 1 Relationships between miR-629-3p and clinicopathologic factors

From: miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer

Variables

miR-629-3p

Correlation coefficient

P value

Low

High

Number of patients (n = 367)

%

Number of patients (n = 158)

%

Age, years

    

−0.016

0.717

  < 35

48

13.1

24

15.2

  

 35–65

291

79.3

121

76.6

  

  > 65

28

7.6

13

8.2

  

Menopause

    

0.077

0.077

 No

230

62.7

86

54.4

  

 Yes

137

37.3

72

45.6

  

T

    

0.071

0.106

 T1

138

37.6

49

31.0

  

 T2

180

49.0

82

51.9

  

 T3

32

8.6

17

10.8

  

 T4

17

4.6

10

6.3

  

N

    

0.139

0.001

 N0

184

50.1

54

34.1

  

 N1

94

25.6

52

32.9

  

 N2

44

12.0

26

16.5

  

 N3

45

12.3

26

16.5

  

TNM stage

    

0.135

0.002

 I

97

26.4

26

16.5

  

 II

165

45.0

68

43.0

  

 III

105

28.6

64

40.5

  

Grade

    

0.054

0.218

 I

67

18.3

18

11.4

  

 II

141

38.4

67

42.4

  

 III

159

43.3

73

46.2

  

Ki-67

    

0.045

0.298

  ≤ 14%

102

27.8

37

23.4

  

  > 14%

265

72.2

121

76.6

  

LVI

    

0.241

<0.001

 Negative

326

88.8

109

69.0

  

 Positive

41

11.2

49

31.0

  
  1. LVI Lymphovascular invasion